Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer
Clinical trial NCT01090128 · TERMINATED
Trial details
- NCT number
- NCT01090128
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2017-03-24
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.